IT1116505B - Formulazione farmaceutica a base di acido(tutto-z)-5,8,11,14,17-eicosa pentaenoico - Google Patents

Formulazione farmaceutica a base di acido(tutto-z)-5,8,11,14,17-eicosa pentaenoico

Info

Publication number
IT1116505B
IT1116505B IT47717/79A IT4771779A IT1116505B IT 1116505 B IT1116505 B IT 1116505B IT 47717/79 A IT47717/79 A IT 47717/79A IT 4771779 A IT4771779 A IT 4771779A IT 1116505 B IT1116505 B IT 1116505B
Authority
IT
Italy
Prior art keywords
tutto
pharmaceutical formulation
acid based
eicosa pentaenoic
formulation acid
Prior art date
Application number
IT47717/79A
Other languages
English (en)
Italian (it)
Other versions
IT7947717A0 (it
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2357578A external-priority patent/GB1604554A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IT7947717A0 publication Critical patent/IT7947717A0/it
Application granted granted Critical
Publication of IT1116505B publication Critical patent/IT1116505B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A23C15/126—Butter containing a minority of vegetable oils; Enrichment of butter with fatty acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT47717/79A 1978-05-26 1979-01-19 Formulazione farmaceutica a base di acido(tutto-z)-5,8,11,14,17-eicosa pentaenoico IT1116505B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2357578A GB1604554A (en) 1978-05-26 1978-05-26 Pharmaceutical and food formulations
GB2357478 1978-05-26

Publications (2)

Publication Number Publication Date
IT7947717A0 IT7947717A0 (it) 1979-01-19
IT1116505B true IT1116505B (it) 1986-02-10

Family

ID=26256599

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47717/79A IT1116505B (it) 1978-05-26 1979-01-19 Formulazione farmaceutica a base di acido(tutto-z)-5,8,11,14,17-eicosa pentaenoico

Country Status (13)

Country Link
JP (1) JPS5515444A (enExample)
AU (1) AU527784B2 (enExample)
CA (1) CA1151068A (enExample)
CH (1) CH644267A5 (enExample)
DE (1) DE2831507A1 (enExample)
ES (1) ES8104983A1 (enExample)
FR (1) FR2426461A1 (enExample)
IE (1) IE48287B1 (enExample)
IL (1) IL55227A (enExample)
IT (1) IT1116505B (enExample)
NL (1) NL191332C (enExample)
NZ (1) NZ187908A (enExample)
SE (1) SE448678B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5735512A (en) * 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
JPS60132916A (ja) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The 血栓症予防食品または医薬品
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
JPH0748991B2 (ja) * 1984-08-29 1995-05-31 日本油脂株式会社 経管栄養組成物
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
NL9401743A (nl) * 1994-10-20 1996-06-03 Prospa Bv Zouten van aminoalcoholen en farmaceutische formuleringen die deze bevatten.
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
DE10056351A1 (de) * 2000-11-14 2002-05-29 Weylandt Karsten Henrich Pharmazeutisches Präparat
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
NZ595789A (en) 2009-04-29 2014-05-30 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
EP2424356B1 (en) 2009-04-29 2017-08-23 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
LT2443246T (lt) 2009-06-15 2018-03-26 Amarin Pharmaceuticals Ireland Limited Kompozicijos ir būdai, skirti trigliceridų sumažinimui, nepakeliant ldl-c lygio subjekte, kartu taikant statino terapiją
NZ599061A (en) 2009-09-23 2014-05-30 Amarin Pharmaceuticals Ie Ltd Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
WO2013070735A1 (en) 2011-11-07 2013-05-16 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US9827219B2 (en) 2012-01-06 2017-11-28 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject
DK4342546T3 (da) 2012-06-29 2025-09-01 Amarin Pharmaceuticals Ie Ltd Eicosapentaensyreethylester til brug for at reducere risikoen for ikke-dødeligt slagtilfælde hos en patient i statinbehandling
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
WO2014123484A1 (en) 2013-02-06 2014-08-14 Agency For Science, Technology And Research Methods For Reducing Aggregate Content In Protein Preparations
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
JP7020756B2 (ja) 2018-09-24 2022-02-16 アマリン ファーマシューティカルズ アイルランド リミテッド 対象の心血管イベントのリスクを低減する方法
CN116350616A (zh) 2019-11-12 2023-06-30 阿马里纳药物爱尔兰有限公司 降低心房纤颤和/或心房扑动受试者心血管事件风险的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE319677B (enExample) * 1965-03-27 1970-01-19 Sumitomo Chemical Co
FR2097036A1 (en) * 1970-07-29 1972-03-03 Sopharga Lab Lipids contg fatty acids - for treatment of atheroslerosis
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
JPS6257605A (ja) * 1985-09-05 1987-03-13 Kaizuka Kazutoshi 多元素鉱物からの有効成分抽出方法

Also Published As

Publication number Publication date
SE7904570L (sv) 1979-11-27
CA1151068A (en) 1983-08-02
FR2426461A1 (fr) 1979-12-21
DE2831507C2 (enExample) 1989-07-13
CH644267A5 (en) 1984-07-31
IL55227A0 (en) 1978-09-29
SE448678B (sv) 1987-03-16
ES480921A0 (es) 1981-05-16
DE2831507A1 (de) 1979-11-29
FR2426461B1 (enExample) 1983-02-11
IE48287B1 (en) 1984-11-28
IT7947717A0 (it) 1979-01-19
JPS5515444A (en) 1980-02-02
IL55227A (en) 1982-12-31
NL7904144A (nl) 1979-11-28
ES8104983A1 (es) 1981-05-16
NL191332B (nl) 1995-01-02
IE791023L (en) 1979-11-26
NZ187908A (en) 1984-05-31
AU527784B2 (en) 1983-03-24
AU3808478A (en) 1980-01-17
NL191332C (nl) 1995-06-01

Similar Documents

Publication Publication Date Title
IT1116505B (it) Formulazione farmaceutica a base di acido(tutto-z)-5,8,11,14,17-eicosa pentaenoico
NZ189574A (en) Dehydrocyclicimino acid derivatives pharmaceutical compositions
DK136579A (da) Thioetiansyrederivater
DK343980A (da) 2,4,6-triiod-isophthalsyrederivater
DK343880A (da) 2,4,6-triiod-isophthalsyrederivater
DK111179A (da) Carbaminsyrederivater
DK317178A (da) Phenyleddikesyrederivater
ES523653A0 (es) Procedimiento de obtencion de composiciones farmaceuticas a base de derivados de acido glicirretinico.
GB2081715B (en) Novel 5-phenylcarbamoylbarbituric acid compounds
IT1120443B (it) Composizioni a base di acido tiazolossammico e procedimento per la loro preparazione
BR7908037A (pt) Derivados de acido fenilciclopropano-carboxilico,processos para sua producao,e composicoes acaricidas e inseticidas a base dos mesmos
IT8024157A0 (it) Ammide dell'acido poliprenilcarbossilico.
IT7928170A0 (it) Composizione farmaceutica a base di acido tiazolidin-4-carbossilico per il trattamento di malattie neoplastiche e metodi di preparazione.
IT1124842B (it) Procedimento di fabbricazione dell'acido para-idrossimandelico racemico
ES488142A0 (es) Un procedimiento para la preparacion de acido 7-metoxi-5-oxo-5h-tiazolo (2,3-b)quinazolin-2-carboxilico
IT1125480B (it) Composto a base di 2,6-diammino-nebularina
ZA792773B (en) Derivatives of 4,5-dihydro-4-oxofuran-2-carboxylic acid
SE8004166L (sv) Cykliska iminokarboxylsyraderivat
IT7950715A0 (it) Composizioni farmaceutiche a basedi ariltrifluotoetanolo
ES488211A0 (es) Un procedimiento para la preparacion del acido 7-oxo-1-aza- biciclo (3.2.0)hept-2-en-2-carboxilico
AU527930B2 (en) 1,3,4-thiadiazole-2-carboxylic acid derivatives
IT7948749A0 (it) Medicamento a base di derivati dell'acido antranilico
FI790329A7 (fi) Foerfarande foer framstaellning av 1-naftylaettiksyraderivat
FI792586A7 (fi) Alfa-aminofenylaettikssyraderivat
GB2012266B (en) 1,5 - cyclohexadienecarbocylic acid derivatives

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960129